WS15.03 Elexacaftor/tezacaftor/ivacaftor population pharmacokinetics in paediatric patients with cystic fibrosis - Université de Reims Champagne-Ardenne Access content directly
Journal Articles Journal of Cystic Fibrosis Year : 2024

WS15.03 Elexacaftor/tezacaftor/ivacaftor population pharmacokinetics in paediatric patients with cystic fibrosis

N.H. Truong
  • Function : Author
S. Benaboud
  • Function : Author
E. Bardin
  • Function : Author
M. Miralles
  • Function : Author
G. Lui
  • Function : Author
L. Froelicher-Bournaud
  • Function : Author
S. Rouillon
  • Function : Author
N. Bouazza
  • Function : Author
N. Stremler
  • Function : Author
T. Bihouee
  • Function : Author
E. Coirier-Duet
  • Function : Author
C. Marguet
  • Function : Author
E. Deneuville
  • Function : Author
M. Laurans
  • Function : Author
P. Reix
  • Function : Author
M. Gerardin
  • Function : Author
M. Mittaine
  • Function : Author
R. Epaud
  • Function : Author
C. Thumerelle
  • Function : Author
L. Weiss
  • Function : Author
J.-M. Treluyer
  • Function : Author
I. Sermet-Gaudelus
  • Function : Author
F. Foissac
  • Function : Author
No file

Dates and versions

hal-04609274 , version 1 (12-06-2024)

Identifiers

Cite

N.H. Truong, S. Benaboud, E. Bardin, M. Miralles, G. Lui, et al.. WS15.03 Elexacaftor/tezacaftor/ivacaftor population pharmacokinetics in paediatric patients with cystic fibrosis. Journal of Cystic Fibrosis, 2024, 23, pp.S28. ⟨10.1016/S1569-1993(24)00195-4⟩. ⟨hal-04609274⟩

Collections

URCA P3CELL
7 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More